Cited by 75Amyotrophic Lateral Sclerosis ResearchGenetic Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Longitudinal imaging in C9ORF72 mutation carriers: relationship to phenotype

Open access
Floeter, Mary Kay, Bageac, Devin, Danielian, Laura E., Braun, Laura E., Traynor, Bryan J., Kwan, Justin Y.·2016·NeuroImage: Clinical

Abstract

Expansion mutations in the C9orf72 gene may cause amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), or mixtures of the two clinical phenotypes. Different imaging findings have been described for C9orf72-associated diseases in comparison with sporadic patients with the same phenotypes, but it is uncertain whether different phenotypes have a common genotype-associated imaging signature. To address this question, 27 unrelated C9orf72 expansion mutation carriers (C9 +) with varied phenotypes, 28 age-matched healthy controls and 22 patients with sporadic ALS (sALS) underwent 3T MRI scanning and clinical phenotyping. Measures of brain volumes and cortical thickness were extracted from T1 images. Compared to healthy controls and sALS patients, symptomatic C9 + subjects had greater ventricular volume loss and thalamic atrophy for age, with diffuse, patchy cortical thinning. Asymptomatic carriers did not differ from controls. C9 + ALS and ALS-FTD patients had less thinning of the motor cortex than sALS patients, but more thinning in extramotor regions, particularly in frontal and temporal lobes. C9 + ALS patients differed from sporadic ALS patients in the thickness of the superior frontal gyrus and lateral orbitofrontal cortex. Thickness of the precentral gyrus was weakly correlated with the revised ALS functional rating scale. Thickness of many cortical regions, including several frontal and temporal regions, was moderately correlated with letter fluency scores. Letter fluency scores were weakly correlated with ventricular and thalamic volume. To better understand how imaging findings are related to disease progression, nineteen C9 + subjects and 23 healthy controls were scanned approximately 6 months later. Ventricular volume increased in C9 + patients with FTD and ALS-FTD phenotypes and remained stable in asymptomatic C9 + subjects. We conclude that diffuse atrophy is a common underlying feature of disease associated with C9orf72 mutations across its clinical phenotypes. Ventricular enlargement can be measured over a 6-month time frame, and appears to be faster in patients with cognitive impairment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.nicl.2016.10.014

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Over varying follow-up (from 6 months to 2.5 years), the increase of grey matter atrophy was associated with various validated clinical measures of disease progression, such as the CDR, CDR-FTD, MMSE, and letter fluency scores.

    “Over varying follow-up (from 6 months to 2.5 years), the increase of GM atrophy was associated with various validated clinical measures of disease progression, such as the CDR, CDR-FTD, MMSE, and, in neuropsychological testing, letter fluency scores (Gordon et al., 2010; Floeter et al., 2016; Staffaroni et al., 2019b; Illán-Gala et al., 2021b).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Floeter, M. K., Bageac, D., Danielian, L. E., Braun, L. E., Traynor, B. J., & Kwan, J. Y.
Affiliations
  • National Institutes of Health (US)
  • University of Maryland, Baltimore (US)
Corresponding author
Floeter, Mary Kay
Venue
NeuroImage: Clinical
Publisher
Elsevier BV
Published
2016-02
Volume
12
Pages
1035-1043
ISSN
2213-1582 (ISSN-L)
OpenAlex
W2535439450
Cited by
75
References
65
Citations by year
2026: 3 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 10 · 2020: 13 · 2019: 10 · 2018: 8 · 2017: 8
FWCI
6.51
Type
journal article
Language
en
Open access
Locations
  • NeuroImage Clinical (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institutes of Health
  • National Institute of Neurological Disorders and Stroke (Z01 NS003146)
  • National Institute on Aging (Z01 AG000933)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyotrophic lateral sclerosis, frontotemporal dementia, ALS-FTD, longitudinal MRI, cortical thinning, ventriculomegaly, thalamic atrophy, brain atrophy, phonemic fluency, cognitive impairment, genotype-phenotype correlation, asymptomatic mutation carriers, sporadic ALS
MeSH terms
C9orf72 Protein, Adult, Aged, Amyotrophic Lateral Sclerosis, Atrophy, Cerebral Cortex, Cerebral Ventricles, Female, Follow-Up Studies, Heterozygote, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Mutation, Phenotype, Disease Progression, Frontotemporal Dementia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review